Fiche publication
Date publication
novembre 2025
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe
,
Dr FACY Olivier
,
Pr PESSAUX Patrick
Tous les auteurs :
Cleret de Langavant B, Voron T, de Montrichard M, Bachelier P, Sulpice L, Carrere N, Gronnier C, Benhaim L, Salamé E, Veziant J, Eveno C, Kianmanesh R, Pessaux P, Mathonet M, Facy O, Lubrano J, Adam R, Piessen G,
Lien Pubmed
Résumé
Oesophageal cancer is metastatic at diagnosis in 40 % of cases, with liver metastasis (LM) being the second most frequent site. In oligometastatic patients, the survival benefit of ablative therapy over chemotherapy remains unclear. This study aims to evaluate the impact of liver resection on overall and progression-free survival in patients with limited LM from Oesophageal Adenocarcinoma (OA) or Siewert I-II Oeso-Gastric Junction Adenocarcinoma (OGJA).
Mots clés
Liver metastases, Liver resection, Oesophageal adenocarcinoma, Oligometastatic disease, Systemic therapy
Référence
Eur J Surg Oncol. 2025 11 5;52(1):111173
